![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/436 | |
A61K 31/445 | |||
A61P 37/00 |
(11) | Number of the document | 1608368 |
(13) | Kind of document | T |
(96) | European patent application number | 04720871.5 |
Date of filing the European patent application | 2004-03-16 | |
(97) | Date of publication of the European application | 2005-12-28 |
(45) | Date of publication and mention of the grant of the patent | 2008-10-01 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2004/002714 |
Date | 2004-03-16 |
(87) | Number | WO 2004/082681 |
Date | 2004-09-30 |
(30) | Number | Date | Country code |
0306070 | 2003-03-17 | GB | |
0306868 | 2003-03-25 | GB | |
0319226 | 2003-08-15 | GB |
(72) |
MOORE, Henrietta, AT
|
(73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
Novartis Pharma GmbH, Brunner Strasse 59, 1230 Wien, AT |
(54) | PHARMACEUTICAL COMPOSITIONS COMPRISING A COMBINATION OF RAPAMYCIN OR ITS DERIVATIVE AND PIMECROLIMUS FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE (IBD) |
PHARMACEUTICAL COMPOSITIONS COMPRISING A COMBINATION OF RAPAMYCIN OR ITS DERIVATIVE AND PIMECROLIMUS FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE (IBD) |